Beyond Air granted U.S. patent for treatment of NTM infections using gaseous Nitric Oxide

featured-image

Beyond Air ( NASDAQ: XAIR ) said on Thursday that the United States Patent and Trademark Office (USPTO) has issued a U.S. Patent.

The issued patent gives the company protection for its method of delivering gaseous nitric oxide to a patient who.